Adenomyosis in a postmenopausal woman: A rare entity

In: Indian Journal of Obstetrics and Gynecology Research · 2022 · vol. 9(3) , pp. 432–434 · doi:10.18231/j.ijogr.2022.083 · W4290652084
article OA: hybrid CC0
AI-generated summary by claude@2026-06, 2026-06-10

This case report describes the diagnosis of adenomyosis, a benign endometrial invasion into the myometrium, in a 68-year-old woman presenting with postmenopausal bleeding.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text

This case report describes a 68-year-old postmenopausal woman with recurrent postmenopausal bleeding over two months, evaluated with pelvic examination, transvaginal sonography, and endometrial biopsy, which suggested endometrial hyperplasia without atypia. Imaging showed an enlarged uterus with diffuse heterogenous myometrial echotexture and small anechoic areas consistent with diffuse adenomyosis, and definitive total abdominal hysterectomy with bilateral salpingo-oophorectomy was performed, with histopathology confirming diffuse adenomyosis plus coexisting subserosal fibroids. A key limitation is that, as a single case report, it cannot establish causality or generalizable prevalence for postmenopausal adenomyosis, though the authors note it is rare after menopause. This paper is centrally about adenomyosis — a rare postmenopausal presentation confirmed histologically.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Adenomyosis is an important clinical challenge in gynecology. It is known as the benign invasion of endometrium into the myometrium. It is usually seen in women of reproductive age group where estrogen plays an important role, rare in postmenopausal women. Here we present a case of a 68-year-old lady who presented to us with postmenopausal bleeding and was found to have adenomyosis.
Full text 9,640 characters · extracted from oa-doi-fallback · 4 sections · click to expand

Abstract

Adenomyosis is an important clinical challenge in gynecology. It is known as the benign invasion of endometrium into the myometrium. It is usually seen in women of reproductive age group where estrogen plays an important role, rare in postmenopausal women. Here we present a case of a 68-year-old lady who presented to us with postmenopausal bleeding and was found to have adenomyosis. Case Report A 68-year-old female presented with recurrent episodes of postmenopausal bleeding over a period of two months. She had attained menopause at the age of 52 years. She was para 4 live 3 with all full term vaginal deliveries at home. She got her bilateral tubal ligation done about 25 years back. There was no significant past history. She had no history of any hormonal treatment in the past. She had normal regular cycles of 4-5 days before menopause. On examination, her vitals were stable. B/L breast soft. Per abdomen-soft, non tender. Per speculum examination revealed hypertrophied cervix. Slight bleeding through os was present. On bimanual examination, uterus was 12-14 weeks size with irregular surface, firm, mobile and tender. There was no adnexal mass. Her laboratory investigations were unremarkable. Pap smear was Negative for Intraepithelial Lesion / Malignancy. Trans Vaginal Sonography showed enlarged uterus with Endometrial Thickness 5.4mm and diffuse heterogenous echotexture of myometrium along with few small anechoic areas within it suggestive of diffuse adenomyosis. Endometrial biopsy was suggestive of endometrial hyperplasia without atypia. Since her bleeding continued, she was taken up for definitive surgery. Total abdominal hysterectomy with bilateral salpingoophrectomy was done. Per operative finding: Uterus was 14 weeks size, firm with irregular surface having two small (2*2 cm) subserosal fibroids one at fundus and other on anterior wall. Cervix was elongated and hypertrophied. Both ovaries were looking normal. Both fallopian tubes showed fallope rings. Cut section of uterine specimen showed thickened myometrium. Histopathological examination of uterus showed non secretory endometrium, multiple foci of endometrial glands and stoma deep in myometrium suggestive of diffuse adenomyosis and two subserosal fibroids and that of cervix showed Chronic cervicitis. A pathological diagnosis of adenomyosis with coexisting fibroid was made. The patient is under follow up.

Discussion

Adenomyosis was first described in 1860 by Von Rokitansky who found a heterotropic occurrence of islands of endometrium scattered throughout myometrium.[1] The current definition of adenomyosis was finally provided in 1972 by Bird who stated ‘Adenomyosis may be defined as the benign invasion of endometrium into the myometrium, producing a diffusely enlarged uterus which microscopically exhibits ectopic non neoplastic endometrial glands and stroma surrounded by the hypertropic and hyperplastic myometrium.[2] Adenomyosis may be diffuse or cystic, diffuse being more common. Adenomyosisis considered a specific entity in the PALM-COEIN classification of causes of abnormal uterine bleeding. The reported incidence of adenomyosis varies widely from 5 to 70% depending on the method used for diagnosis with a median incidence of 20 to 30%.[3] The exact pathogenesis of adenomyosis is not known. Adenomyosis may occur by invagination of basal endometrium into myometrium and metaplasia of Mullerian rests in the myometrium. The common risk factors for adenomyosis include age more than 40 years, multiparity, previous caesarean section or uterine surgery.[3] But the epidemiological scenario has changed. The disease is increasingly being diagnosed in young women, in women with infertility[4] or in those with pain or abnormal uterine bleeding or both.[5] Adenomyosis regresses after menopause. So its presence in postmenopausal women is rare. The reported incidence of adenomyosis among postmenopausal women was 0.49% by Dr Akhtar Un Nisha Salaria et al,[6] 0.8% by Arunachalam B et al,[7] and 9% by Shaikh H et al.[8] Upto 30% of patients with adenomyosis remain asymptomatic. Symptomatic women present with heavy menstrual bleeding, congestive dysmenorrhea, chronic pelvic pain, dyspareunia and infertility. Bimanual examination reveals uniformly enlarged (Not more than 12 weeks size) tender uterus. However, the findings may be altered due to coexisting fibroid or pelvic endometriosis. In our case, uterus was 14 weeks size with irregular surface due to coexisting subserous fibroids. The introduction of imaging techniques such as Trans vaginal sonography and Magnetic Resonance Imaging has allowed to establish pre operative diagnosis of adenomyosis. The features indicative of adenomyosis on pelvic ultrasound include enlarged globular uterus, asymmetrical thickening of myometrium, myometrial cysts, echogenic subendometrial linings and buds, hyperechoic islands, fan shaped shadowing, an irregular or interrupted junctional zone and translesional vascularity on colour Doppler (MUSA criteria).[9] The junctional zone at the endometrial-myometrial interface may be assessed by three dimensional TVS and MRI. Definitive diagnosis of adenomyosis can be made hisologically only when endometrial stroma and glandular tissue is found within the myometrium. Different criteria for required depth of invasion exist, some using an absolute measurement between 2.5 to 8mm while others use a percentage of myometrial involvement Traditionally diagnosis is made when endometrial tissue has invaded more than 2% of myometrium or a minimum depth of invasion is equal to or more than 4 mm beneath the endomyometrial junction.[10] While planning treatment for adenomyosis, two factors are important, age of patient and her desire for future fertility. The definitive treatment of symptomatic adenomyosis is hysterectomy, but it may not be an option in patients who are young, who desire future fertility or who are poor surgical candidates. For these patients, treatment options include medical treatment such as Non Steroidal Anti Inflammatory drugs used to control pain and bleeding, Combined Oral Contraceptive pills (though not found very useful). LNG intrauterine system, GnRH analogues and Danazol, Conservative surgery such as resection of adenomyoma, myometrial reduction or newer interventional techniques such as uterine artery embolization. Our case was postmenopausal, so total hysterectomy with bilateral salpingoophrectomy was the definitive treatment for her.

Conclusion

In conclusion, adenomyosis is a benign but often progressive condition. It is very rare in postmenopausal women. As the condition is estrogen dependent, menopause presents a natural cure. Still, very rarely as seen here, adenomyosis can present in the seventies or beyond. Source of Funding None. Conflict of Interest None.

References

- Cucinella G, Billone V, Pitruzzella I. Adenomyotic cyst in a 25-year-old woman: case report. J Minim Invasive Gynecol. 2013;20(6):894-8. [Google Scholar] - Benagiana G, Brosens I. Brosens I History of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):449-63. [Google Scholar] - Vercellini P, Viganò P, Somigliana E, Daguati R, Abbiati A, Fedele L. Adenomyosis: epidemiological factors. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):465-77. [Google Scholar] - Puente J, Fabris A, Patel J, AP, MC, Requena A. Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease. Reprod Biol Endocrinol. 2016;14(1). [Google Scholar] - Naftalin J, Hoo W, Pateman K, Mavrelos D, Foo X, Jurkovic D. Is adenomyosis associated with menorrhagia?. Hum Reprod. 2014;29(3):473-9. [Google Scholar] - Salaria A, Singh J. Prevalence of Adenomyosis in Hysterectomy Specimen in Jammu Region and its Clinical Correlations in a Tertiary Care Hospital. J Med Sci Clin Res. 2019;7(7):738-42. [Google Scholar] - Arunachalam B, Manivasakan J. A clinico - Pathological study of adenomyosis. J Clin Diagn Res. 2012;6:428-30. [Google Scholar] - Shaikh H, Khan K. Adenomyosis in Pakistani women: four year experience at the Aga Khan University Medical Centre, Karachi. J Clin Pathol. 1990;43(10):817-9. [Google Scholar] - Champaneria R, Abedin P, Daniels J. Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy. Acta Obstet Gynecol Scand. 2010;89(11):1374-84. [Google Scholar] - Sagar N, Tomar R, Balhara K, Mallya V, Mandal S, Khurana N. Histopathological Association of Adenomyosis with Various Gynaecological Pathologies. Ann Pathol Lab Med. 2020;7(2):221-3. [Google Scholar] How to Cite This Article Vancouver Upreti P, Godara P. Adenomyosis in a postmenopausal woman: A rare entity [Internet]. Indian J Obstet Gynecol Res. 2022 [cited 2026 Jul 09];9(3):432-434. Available from: https://doi.org/10.18231/j.ijogr.2022.083 APA Upreti, P., Godara, P. (2022). Adenomyosis in a postmenopausal woman: A rare entity. Indian Journal of Obstetrics and Gynecology Research, 9(3), 432-434. https://doi.org/10.18231/j.ijogr.2022.083 MLA Upreti, Purnima, Godara, Punam. "Adenomyosis in a postmenopausal woman: A rare entity." Indian J Obstet Gynecol Res, vol. 9, no. 3, 2022, pp. 432-434. https://doi.org/10.18231/j.ijogr.2022.083 Chicago Upreti, P., Godara, P.. "Adenomyosis in a postmenopausal woman: A rare entity." Indian J Obstet Gynecol Res 9, no. 3 (2022): 432-434. https://doi.org/10.18231/j.ijogr.2022.083

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (9)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK